Side Effects of Yttrium-90 Radioembolization [PDF]
Frontiers in Oncology, 2014 Limited therapeutic options are available for hepatic malignancies. Image guided targeted therapies have established their role in management of primary and secondary hepatic malignancies.
Ahsun eRiaz, Rafia eAwais, Riad eSalem
doaj +2 more sources
Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma [PDF]
Journal of Hepatocellular Carcinoma, 2016 Armeen Mahvash,1 Ravi Murthy,1 Bruno C Odisio,1 Kanwal Pratap Raghav,2 Lauren Girard,2 Sheree Cheung,1 Van Nguyen,3 Joe Ensor,4 Sameer Gadani,5 Khaled M Elsayes,6 Reham Abdel-Wahab,1,7 Manal Hassan,1 Ahmed S Shalaby,1 James C Yao,1 Michael J Wallace,1 ...
Mahvash A +15 more
doaj +1 more source
Yttrium-90 Microsphere Radioembolization for Treatment of Lung Cancer Hepatic Metastases [PDF]
Case Reports in Oncology, 2012 Because stage 4 lung cancer is associated with dismal 5-year survival rates, new treatment approaches targeting extrapulmonary disease are necessary. Yttrium-90 microsphere radioembolization is an emerging treatment for metastatic hepatic malignancies ...
Ron C. Gaba, Janesh Lakhoo
doaj +2 more sources
Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments [PDF]
Journal of Hepatocellular Carcinoma, 2014 Alberta Cappelli,1 Cinzia Pettinato,2 Rita Golfieri1 1Radiology Unit, 2Medical Physics Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum – University of Bologna, S Orsola-Malpighi Hospital, Bologna, Italy Abstract: A ...
Cappelli A, Pettinato C, Golfieri R
doaj +1 more source
Effect of Yttrium-90 transarterial radioembolization in patients with non-surgical hepatocellular carcinoma: A systematic review and meta-analysis. [PDF]
PLoS ONE, 2021 BackgroundRecently, the use of Yttrium-90 transarterial radioembolization in non-surgical hepatocellular carcinoma was suggested but the evidence supporting its use is unclear.MethodsWe searched Medline, Embase, Web of Science and Cochrane CENTRAL from ...
Simon Lemieux +6 more
doaj +2 more sources
Yttrium-90 Radioembolization of Hepatic Metastases from Colorectal Cancer [PDF]
Frontiers in Oncology, 2014 Liver metastases from colorectal cancer (CRC) result in substantial morbidity and mortality. The primary treatment is systemic chemotherapy, and in selected patients, surgical resection; however, for patients who are not surgical candidates and/or fail ...
Raval eMihir +6 more
doaj +3 more sources
, 2021 Transarterial radioembolization with yttrium-90 ( (90) Y) is a mainstay for the treatment of liver cancer. Imaging the distribution following delivery is a concept that dates back to the 1960s.
Rice, Mitchell +2 more
core +1 more source
Hypertrophieinduktion des linken Leberlappens nach rechtshepatischer Yttrium-90-Radioembolisation im Vergleich zur Pfortaderembolisation [PDF]
, 2022 Die vorliegende Arbeit beinhaltet die Evaluation der Hypertrophieinduktion des linken Leberlappens nach zwei verschiedenen Embolisationsverfahren im rechten Leberlappen: der Pfortaderembolisation und der transarteriellen Yttrium-90-Radioembolisation. Zur
Damm, Romy
core +1 more source
Liver abscess following radioembolization with yttrium-90 microspheres [Leberabszess nach Radioembolisation mit Yttrium-90 Mikrosphären] [PDF]
, 2014 Radioembolization with yttrium-90 microspheres is an accepted and useful intervention model with minimal invasion in both primary and secondary liver malignancies. Radioembolization may lead to some complications.
Parildar M. +6 more
core +3 more sources
Additional file 1 of Active bone marrow S-values for the low-energy electron emitter terbium-161 compared to S-values for lutetium-177 and yttrium-90 [PDF]
, 2022 Additional file 1: Table S1. Tissue data from University of Florida Adult Male Hybrid Phantom. Table S2. Tissue data from University of Florida Adult Female Hybrid Phantom. Table S3.
Nicholas P. van der Meulen (5802245) +4 more
core +1 more source